2014
DOI: 10.1002/14651858.cd003458.pub5
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacological and nutritional treatment for McArdle disease (Glycogen Storage Disease type V)

Abstract: Trusted evidence. Informed decisions. Better health. Cochrane Database of Systematic Reviews Characteristics of excluded studies [ordered by study ID] Study Reason for exclusion Pharmacological and nutritional treatment for McArdle disease (Glycogen Storage Disease type V) (Review)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
26
0
4

Year Published

2014
2014
2023
2023

Publication Types

Select...
6
1
1

Relationship

1
7

Authors

Journals

citations
Cited by 69 publications
(30 citation statements)
references
References 54 publications
0
26
0
4
Order By: Relevance
“…A Cochrane review from 2014 found no new trials since the previous review in 2004 29. The management currently relies on attempting to reduce the risk of developing episodes of rhabdomyolysis.…”
Section: An Overview Of Some Diseases To Consider In Adultsmentioning
confidence: 99%
“…A Cochrane review from 2014 found no new trials since the previous review in 2004 29. The management currently relies on attempting to reduce the risk of developing episodes of rhabdomyolysis.…”
Section: An Overview Of Some Diseases To Consider In Adultsmentioning
confidence: 99%
“…The interpretation is that a decreased central drive to ventilate in postmenopausal women allowed for small increases in PCO 2 McArdle's syndrome (glycogen-storage disease type V), characterized by the absence of functional glycogen phosphorylase in striated muscle, mainly results from a missense mutation in the myophosphorylase (PYGM) gene (245). Affected individuals experience reduced exercise tolerance, muscle fatigability, and weakness; muscle cramps and pain can be provoked by exercise.…”
Section: Menopausementioning
confidence: 99%
“…However, when carbon for oxidative phosphorylation is provided as exogenous glucose or fatty acids, there appears to be no impairment of oxidative phosphorylation (166). Therefore, muscle activity is highly dependent on free fatty acid (FFA) and amino acid oxidation (245). Accordingly, oxygen consumption is 35% to 40% of that seen in normal muscle when inadequate substrate for oxidation is provided (166).…”
Section: Menopausementioning
confidence: 99%
“…While many studies have explored dietary intervention in McArdle disease, at present there are no nutritional or pharmacological treatment recommendations [10]. As such, patients are left to explore alternative options (such as a LCKD) to address the insidious effects of this glycogen storage disease.…”
Section: Introductionmentioning
confidence: 99%